Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Síndrome Coronario Agudo")

Vivas, David; García-Rubira, Juan C.; Bernardo, Esther; Angiolillo, Dominick J.; Martín, Patricia; Calle-Pascual, Alfonso; Núñez-Gil, Iván; Macaya, Carlos; Fernández-Ortiz, Antonio
May 2011
Heart;May2011, Vol. 97 Issue 10, p6
Academic Journal
The article discusses the CHIP study on the functional impact of intensive glucose control with insulin on platelet reactivity in patients with acute coronary syndrome (ACS) and hyperglycaemia. Two groups of patients underwent random assignment with 59 of them assigned to intensive and 56 to conventional glucose control. The findings shows reduced platelet reactivity with intensive glycaemic control and provides insights into how the strategy may contribute to improve the cardiovascular outcome among patients with ACS presenting with hyperglycaemia.


Related Articles

  • HIPERGLUCEMIA EN EL S�NDROME CORONARIO AGUDO INFORME CIENT�FICO MULTIDISCIPLINARIO. Blanco, Patricia; Benzad�n, Mariano; Arazi, Hern�n Cohen; Duronto, Ernesto; Higa, Claudio; Gonz�lez, Miguel A.; Mele, Eduardo // Medicina (Buenos Aires);2012, Vol. 72 Issue 1, p135 

    Hyperglycemia with or without pre-existing diabetes mellitus, occurs frequently in the setting of acute coronary syndrome. Previous studies have demonstrated that hyperglycemia is highly prevalent and is associated with an increased risk of hospital complications and death. The underlying...

  • Alogliptin EXAMINEd: no increased risk of heart failure outcomes.  // Reactions Weekly;Mar2015, Vol. 1543 Issue 1, p9 

    The article discusses the study which shows that alogliptin does not increase the risk of heart failure outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome (ACS).

  • NICE guidance on hyperglycaemia and acute coronary syndromes. Linden, Belinda // British Journal of Cardiac Nursing;Jun2012, Vol. 7 Issue 6, p284 

    The article summarizes the key recommendations of new guidance published by the National Institute for Health and Clinical Excellence (NICE) on the management of hyperglycaemia in people admitted to hospital with acute coronary syndromes. The guidance offers best practice advice and recommends...

  • Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE study. Vergès, Bruno; Patois-Vergès, Bénédicte; Iliou, Marie-Christine; Simoneau-Robin, Isabelle; Bertrand, Jean-Henri; Feige, Jean-Michel; Douard, Hervé; Catargi, Bogdan; Fischbach, Michel // BMC Cardiovascular Disorders;Jul2015, Vol. 15 Issue 1, p1 

    Background: Gain in VO2 peak after cardiac rehabilitation (CR) following an acute coronary syndrome (ACS), is associated with reduced mortality and morbidity. We have previously shown in CR, that gain in VO2 peak is reduced in Type 2 diabetic patients and that response to CR is impaired by...

  • Insulin Receptor Substrate-1 Expression Is Increased in Circulating Leukocytes of Patients with Acute Coronary Syndrome. Jiménez-Navarro, Manuel F.; Bueno, Héctor; Alvarez-Sala, Luis; Rodríguez-Losada, Noela; Andrés, Vicente; González-Navarro, Herminia // ISRN Cardiology;2011, Special section p1 

    The mechanisms underlying the increased risk of cardiovascular disease associated with diabetes mellitus (DM) are not fully defined. Insulin resistance in human metabolic syndrome patients is associated with decreased expression of the insulin receptor substrate-2- (Irs2-) AKT2 axis in...

  • Comparison of Diagnostic Criteria to Detect Undiagnosed Diabetes in Acute Coronary Syndrome Patients with Admission Hyperglycemia. Alam, Mohammad Sarwar; Khan, H. I. Lutfur Rahman; Chowdhury, Abdul Wadud; Nurus Sabah, Khandker Md.; Amin, Md Gaffar; Jahan Kabir, SM Eftar; Abdullah, Abu Sadique; Hossain, Mofazzal; Khan, Tunaggina Afrin; Shahidullah, Md Sk // Cardiovascular Journal;2015, Vol. 8 Issue 1, p35 

    Background: Diabetes mellitus is one of the most important risk factors of coronary artery disease. Admission hyperglycemia adversely influences the outcome of acute coronary syndrome patients. The study was conducted to compare the various diagnostic methods for the detection of undiagnosed...

  • Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy Can be Safely Used in the Hospital in Select Patients. Rachel Bailon; Brenda Partlow; Victoria Miller-Cage; Mary Boyle; Janna Castro; Peggy Bourgeois; Curtiss Cook // Endocrine Practice;Jan2009, Vol. 15 Issue 1, p24 

    Objective: To analyze data on inpatient insulin pump use and examine staff compliance with hospital procedures, glycemic control, and safety.Methods: We conducted a retrospective review of charts and bedside glucose data for patients who had been receiving outpatient insulin pump therapy and...

  • Effective intravenous to subcutaneous insulin protocol.  // Diabetes Digest;2011, Vol. 10 Issue 3, p175 

    The article focuses on the study which shows the efficacy of the protocol for transition from intravenous to subcutaneous insulin therapy in acute coronary syndromes patients conducted by F. Avanzini and colleagues.

  • Cardiovascular highlights from non-cardiology journals/GENERAL CARDIOLOGY, INTERVENTIONAL CARDIOLOGY. Lindsay, Alistair C.; Contractor, Hussain // Heart;Sep2012, Vol. 98 Issue 18, p1391 

    The article presents abstracts on medical topics which include the benefits of glucose-insulin-potassium in acute coronary syndrome, surgery for endocarditis and anticoagulation.


Read the Article


Sign out of this library

Other Topics